[1] World Health Organization Official Website.
https://www.who.int
[2] Novel Corona Virus (COVID19) Situation Reports. World Health Organisation.
[3] National Guideline on Clinical Management of Coronavirus Disease 2019 (COVID-19).
https://www.dghs.gov.bd
[4] Naicker, S., Yang, C.-W., Hwang, S.-J., et al. (2020) The Novel Coronavirus 2019 Epidemic and Kidneys. Kidney International, 97, 824-828.
https://doi.org/10.1016/j.kint.2020.03.001
[5] System USRD. National Institute Heal National Inst Diabetes Dig Kidney Dis. 2018. 2018 USRDS annual Report: Epidemiology of Kidney Disease in the United States; 1-78.
[6] CDC Mar 2020, International Society of Nephrology Mar 2020, European Renal Association-European Dialysis and Transplant Association.
[7] Wang, D., Hu, B., Hu, C., et al. (2020) Clinical Characteristics of 138 Hospitalized Patients with 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China. JAMA, 323, 1061-1069.
https://doi.org/10.1001/jama.2020.1585
[8] Gao, Y., Li, T.T., Han, M.F., et al. (2020) Diagnostic Utility of Clinical Laboratory Data Determinations for Patients with the Severe COVID-19. Journal of Medical Virology, 1-6.
https://doi.org/10.1002/jmv.25770
[9] Diagnosis and Treatment Protocol for Novel Corona Virus Pneumonia (Trial Version 7).
http://www.kankyokansen.org/uploads/uploads/files/jsipc/protocol_v7.pdf2020
[10] Huang, C., Wang, Y., Li, X., et al. (2020) Clinical Features of Patients Infected with 2019 Novel Coronavirus in Wuhan, China. Lancet, 395, 497-506.
https://doi.org/10.1016/S0140-6736(20)30183-5
[11] Liu, W.J., Zhao, M., Liu, K., et al. (2017) T-Cell Immunity of SARS-CoV: Implications for Vaccine Development against MERS-CoV. Antiviral Research, 137, 82-93.
https://doi.org/10.1016/j.antiviral.2016.11.006
[12] Wong, P.N., Mak, S.K., Lo, K.Y., et al. (2003) Clinical Presentation and Outcome of Severe Acute Respiratory Syndrome in Dialysis Patients. American Journal of Kidney Diseases, 42, 1075-1081.
https://doi.org/10.1016/j.ajkd.2003.08.005